Cancer Genetics
Rutherford, US · Delaware corporation
Find your way into Cancer Genetics
Sign up to see every warm intro you have to Cancer Genetics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cancer Genetics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Board
JP
John PappajohnBoard director
HM
Howard McLeodBoard director
FG
Franklyn G. PrendergastBoard director
MJ
Michael J. WelshBoard director
GH
Geoffrey HarrisBoard director
EC
Edmund CannonBoard director
Reported raises · per SEC filings
Form D private placements$26.5M disclosed across 4 rounds · 2016–2021
▶$10MraisedFeb 2021 · 6 investors · BiotechnologyRule 506(b)
▶$10MraisedFeb 2021 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- John A. RobertsExecutive Officer
- Howard McLeodDirector
- Geoffrey HarrisDirector
- Franklyn G. PrendergastDirector
- Edmund CannonDirector
- Offering amount
- $10M
- Amount sold
- $10M
- Sales commissions
- $775K
- Placement agents
- H.C. Wainwright & Co., LLC
- First sale
- Feb 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6MraisedMar 2017 · 3 investors · BiotechnologyRule 506(b)
▶$6MraisedMar 2017 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Franklyn G. PrendergastDirector
- Howard McLeodDirector
- Geoffrey HarrisDirector
- Michael J. WelshDirector
- John A. RobertsExecutive Officer
- Edmund CannonDirector
- Panna L. SharmaExecutive Officer, Director
- Raju S.K. ChagantiDirector
- John PappajohnDirector
- Offering amount
- $6M
- Amount sold
- $6M
- First sale
- Mar 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.5MraisedDec 2016 · 16 investors · BiotechnologyRule 506(b)
▶$5.5MraisedDec 2016 · 16 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael J. WelshDirector
- Raju S.K. ChagantiExecutive Officer, Director
- Geoffrey HarrisDirector
- Howard McLeodDirector
- John PappajohnDirector
- Franklyn G. PrendergastDirector
- John A. RobertsExecutive Officer
- Edward SitarExecutive Officer
- Edmund CannonDirector
- Panna L. SharmaExecutive Officer, Director
- Offering amount
- $5.5M
- Amount sold
- $5.5M
- Sales commissions
- $385K
- Placement agents
- H.C. WainWright & Co., LLC
- First sale
- Sep 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5MraisedMay 2016 · 41 investors · BiotechnologyRule 506(b)
▶$5MraisedMay 2016 · 41 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Raju S.K. ChagantiExecutive Officer, Director
- Howard McLeodDirector
- Franklyn G. PrendergastDirector
- Panna L. SharmaExecutive Officer, Director
- Edward SitarExecutive Officer
- John PappajohnDirector
- Michael J. WelshDirector
- Geoffrey HarrisDirector
- Edmund CannonDirector
- Offering amount
- $5M
- Amount sold
- $5M
- Sales commissions
- $350K
- Placement agents
- H.C. WainWright & Co., LLC
- First sale
- May 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Cancer Genetics?
- Cancer Genetics was founded by Raju S.K. Chaganti.
- How much funding has Cancer Genetics raised?
- Cancer Genetics has disclosed $26.5M raised across 4 rounds.
- Where is Cancer Genetics headquartered?
- Cancer Genetics is headquartered in Rutherford, US.